The global Aplastic Anemia Market, valued at US$ 6.7 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2034, reaching US$ 10.8 billion by 2034. Aplastic anemia, a rare condition characterized by bone marrow failure leading to low blood cell production, affects approximately 2–6 per million people annually. The market encompasses treatme... https://www.transparencymarketresearch.com/aplastic-anemia-market.html